Type 1 cannabinoid receptor (CB1) levels decline in the striatum of animal models of Huntington’s disease (HD) and in the brains of human patients suffering from HD prior to other pathogenic changes.
Laprairie, Robert
core
Brain cannabinoid CB1 receptor signaling modulates reward responses and inhibitory control in humans. [PDF]
Sun L +4 more
europepmc +1 more source
Cannabinoid tolerance relies on CB<sub>1</sub> receptor ubiquitination by NEDD4L. [PDF]
Álvaro-Blázquez A +10 more
europepmc +1 more source
Endocannabinoid system attenuates emotional stress-induced orofacial musculoskeletal pain in rats. [PDF]
Silveira SS +8 more
europepmc +1 more source
Emerging roles of cannabinoid pathways in renal injury and repair. [PDF]
Romero-Guevara R +2 more
europepmc +1 more source
The Relationship Between (Endo)cannabinoids, the Microbiome and Melanoma. [PDF]
Javid FA +3 more
europepmc +1 more source
Modulation of spatial learning and memory by cannabinoid-estrogen interaction in an AD-like cognitive impairment: The role of cannabinoid receptors and BDNF protein. [PDF]
Mirshekar MA +3 more
europepmc +1 more source
Pharmacological Switching in Minor Phytocannabinoids: A Mechanistic Framework for Compound-Indication Matching and Precision Neurotherapeutic Development. [PDF]
Bagher AM.
europepmc +1 more source
Dimethylindanoylindole Isomers Revealed Different Pharmacological Profiles at CB1 and CB2 Cannabinoid Receptors. [PDF]
Oh SJ +8 more
europepmc +1 more source

